Skip to main content
. 2009 Aug 5;297(4):C955–C970. doi: 10.1152/ajpcell.00140.2009

Fig. 10.

Fig. 10.

Cell-permeant PKA inhibitory peptide 14–22 amide (PKAiP) occludes Ca2+ current enhancement in S100A1-treated neurons. A: average I-Vstep relationships for control, S100A1-treated, and PKAiP-preincubated and S100A1-treated neurons. B: summary of effect of PKAiP on maximum inward Ca2+ current (ICa) of S100A1-treated neurons. Peak Ca2+ current density in S100A1-treated neurons was 18.1 ± 2.5 pA/pF vs. 10.6 ± 2.4 pA/pF for PKAiP and S100A1-treated neurons (*P < 0.05, n = 12/group).